guest ::
| Home > Publications database > MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. > print |
| Home > Publications database > MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. > print |
| 001 | 143394 | ||
| 005 | 20240229112551.0 | ||
| 024 | 7 | _ | |a 10.1158/0008-5472.CAN-18-1787 |2 doi |
| 024 | 7 | _ | |a pmid:30862721 |2 pmid |
| 024 | 7 | _ | |a 0008-5472 |2 ISSN |
| 024 | 7 | _ | |a 0099-7013 |2 ISSN |
| 024 | 7 | _ | |a 0099-7374 |2 ISSN |
| 024 | 7 | _ | |a 1538-7445 |2 ISSN |
| 024 | 7 | _ | |a altmetric:57012378 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2019-00982 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Tao, Ran |b 0 |
| 245 | _ | _ | |a MYC drives Group 3 medulloblastoma through transformation of Sox2+ astrocyte progenitor cells. |
| 260 | _ | _ | |a Philadelphia, Pa. |c 2019 |b AACR |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1562077187_20048 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a ;79(8):1967-1980 |
| 520 | _ | _ | |a A subset of Group 3 medulloblastoma frequently harbors amplification or overexpression of MYC lacking additional focal aberrations, yet it remains unclear whether MYC overexpression alone can induce tumorigenesis and which cells give rise to these tumors. Here, we showed that astrocyte progenitors in the early postnatal cerebellum were susceptible to transformation by MYC. The resulting tumors specifically resembled human Group 3 medulloblastoma based on histology and gene expression profiling. Gene expression analysis of MYC-driven medulloblastoma cells revealed altered glucose metabolic pathways with marked overexpression of lactate dehydrogenase A (LDHA). LDHA abundance correlated positively with MYC expression and was associated with poor prognosis in human Group 3 medulloblastoma. Inhibition of LDHA significantly reduced growth of both mouse and human MYC-driven tumors but had little effect on normal cerebellar cells or SHH-associated medulloblastoma. By generating a new mouse model, we demonstrated for the first time that astrocyte progenitors can be transformed by MYC and serve as the cells of origin for Group 3 medulloblastoma. Moreover, we identified LDHA as a novel, specific therapeutic target for this devastating disease. |
| 536 | _ | _ | |a 312 - Functional and structural genomics (POF3-312) |0 G:(DE-HGF)POF3-312 |c POF3-312 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Murad, Najiba |b 1 |
| 700 | 1 | _ | |a Xu, Zhenhua |b 2 |
| 700 | 1 | _ | |a Zhang, Peng |b 3 |
| 700 | 1 | _ | |a Okonechnikov, Konstantin |0 P:(DE-He78)34b3639de467b2c700920d7cbc3d2110 |b 4 |u dkfz |
| 700 | 1 | _ | |a Kool, Marcel |0 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8 |b 5 |u dkfz |
| 700 | 1 | _ | |a Rivero-Hinojosa, Samuel |b 6 |
| 700 | 1 | _ | |a Lazarski, Christopher |b 7 |
| 700 | 1 | _ | |a Zheng, Pan |0 0000-0003-2598-3544 |b 8 |
| 700 | 1 | _ | |a Liu, Yang |b 9 |
| 700 | 1 | _ | |a Eberhart, Charles G |b 10 |
| 700 | 1 | _ | |a Rood, Brian R |0 0000-0003-3221-9421 |b 11 |
| 700 | 1 | _ | |a Packer, Roger |b 12 |
| 700 | 1 | _ | |a Pei, Yanxin |b 13 |
| 773 | _ | _ | |a 10.1158/0008-5472.CAN-18-1787 |g p. canres.1787.2018 - |0 PERI:(DE-600)2036785-5 |n 8 |p 1967-1980 |t Cancer research |v 79 |y 2019 |x 1538-7445 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:143394 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)34b3639de467b2c700920d7cbc3d2110 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8 |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-312 |2 G:(DE-HGF)POF3-300 |v Functional and structural genomics |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2019 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CANCER RES : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CANCER RES : 2017 |
| 920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l Pädiatrische Neuroonkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B062-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L101-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|